Trial intelligence / Profile preview

Excedrin Migraine vs IV Prochlorperazine for Acute Migraine

NCT01629329Phase 4Terminated

Sponsor
Einstein Healthcare Network
Start
Nov 2010
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetaminophen + aspirin + caffeine in migraine, sponsored by Einstein Healthcare Network. Started Nov 2010; status: terminated.

02

Drugs

acetaminophen + aspirin + caffeine
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01629329.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01629329.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call